BioImage

Infobox Company
company_name = BioImage
company_
company_type = Private
foundation = 1999
location = Soeborg, Denmark
key_people = Patrik Dahlén (CEO) Steven Butcher, (CSO) Edwin Moses (Chairman of the Board) Axel Ullrich (Chairman of the Scientific Advisory Board)
industry = Biotechnology
products = licensing and services around the proprietary Redistribution^TM drug discovery technology
revenue = (not available)
homepage = http://www.bioimage.com/

BioImage is a Danish biotechnology company that was demerged from Novo Nordisk in 1999.

BioImage specializes in developing and selling proprietary bioassays to biopharmaceutical companies and research institutions. It also develops bioassays on a contract service basis.

The company has made broad patents covering "any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays." This intellectual property, trademarked Redistribution, allows many collaborations and out-licensing activities with biopharmaceutical companies. [ [http://www.bioimage.com/technology.htm overview / technology & applications / BioImage ] ]

In April 2006, BioImage was acquired by Thermo Fisher Scientific. The merger was complete in November 2006. [http://www.bioimage.com/pdf/CEOletter.pdf]

References